Milito, C.; Cinetto, F.; Palladino, A.; Garzi, G.; Punziano, A.; Lagnese, G.; Scarpa, R.; Rattazzi, M.; Pesce, A.M.; Pulvirenti, F.;
et al. Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy. Biomedicines 2022, 10, 1026.
https://doi.org/10.3390/biomedicines10051026
AMA Style
Milito C, Cinetto F, Palladino A, Garzi G, Punziano A, Lagnese G, Scarpa R, Rattazzi M, Pesce AM, Pulvirenti F,
et al. Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy. Biomedicines. 2022; 10(5):1026.
https://doi.org/10.3390/biomedicines10051026
Chicago/Turabian Style
Milito, Cinzia, Francesco Cinetto, Andrea Palladino, Giulia Garzi, Alessandra Punziano, Gianluca Lagnese, Riccardo Scarpa, Marcello Rattazzi, Anna Maria Pesce, Federica Pulvirenti,
and et al. 2022. "Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy" Biomedicines 10, no. 5: 1026.
https://doi.org/10.3390/biomedicines10051026
APA Style
Milito, C., Cinetto, F., Palladino, A., Garzi, G., Punziano, A., Lagnese, G., Scarpa, R., Rattazzi, M., Pesce, A. M., Pulvirenti, F., Di Napoli, G., Spadaro, G., Carsetti, R., & Quinti, I.
(2022). Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy. Biomedicines, 10(5), 1026.
https://doi.org/10.3390/biomedicines10051026
